Levetiracetam Biogaran (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which plays a crucial role in the regulation of neurotransmitter release. This binding modulates calcium‑dependent exocytosis, leading to a reduction in the release of excitatory neurotransmitters and thereby decreasing neuronal hyperexcitability that triggers seizures.

The dosage of Levetiracetam Biogaran is individualized and must be determined by a qualified prescriber based on the patient’s age, weight, renal function, and seizure type. Physicians typically start with a low dose and titrate upward to achieve optimal seizure control while monitoring tolerability.

Levetiracetam is classified as pregnancy category unknown, meaning its safety has not been fully established. It should only be used during pregnancy or lactation if the potential benefit outweighs the possible risk. Patients should discuss their specific situation with a healthcare professional before continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Levetiracetam Biogaran. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism of action by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a favorable pharmacokinetic profile, and is often chosen when patients experience side effects or inadequate control with other agents.

Levetiracetam Biogaran tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

The medication is supplied as oral tablets and should be swallowed whole with a glass of water. It can be taken with or without food, but consistency with regard to meals helps maintain steady plasma concentrations.

Serious adverse events, although rare, include severe allergic reactions (rash, swelling, breathing difficulty), significant psychiatric changes such as depression, anxiety or suicidal thoughts, and hematologic abnormalities like thrombocytopenia or leukopenia. Immediate medical attention is required if any of these symptoms appear.

Patients with a known hypersensitivity to levetiracetam or any component of the tablet should avoid its use. Caution is also advised for individuals with severe renal impairment, as dose adjustment may be required, and for those with a history of serious psychiatric disorders until evaluated by a clinician.